kezar life sciences share price

Based on our forecasts a long-term increase is expected the 2KZ stock price prognosis for 2026-07-17 is 7952 EUR. Get Kezar Life Sciences Inc KZRNASDAQ real-time stock quotes news price and financial information from CNBC.

Possible Turnaround For Kezar Life Sciences Inc Nasdaq Kzr Insiders Still Down Us 17k After A Us 1 3m Shopping Spree

Kezar Life Sciences Inc Shares Near 52-Week High - Market Mover.

. The stock was acquired at an average price of 1477 per share for a total transaction of 29540000. KZR stock price news historical charts analyst ratings and financial information from WSJ. With a 5-year investment the revenue is expected to be around 8238.

Get the latest info and learn more about Kezar Life Sciences IncKZR. KZR stock price quote stock graph news analysis. 102 rows Discover historical prices for KZR stock on Yahoo Finance.

View real-time stock prices and stock quotes for a full financial overview. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders today announced that the Compensation Committee of the companys Board of Directors granted two employees. Summary of all time highs changes and price drops for Kezar Life Sciences.

Kezar Life Sciences Inc. 5 rows Real time Kezar Life Sciences Inc. Kezar Life Sciences Inc.

Their forecasts range from 1400 to 2200. Stock news by MarketWatch. Kezar Life Sciences Inc.

Maintained a Buy rating on the stock and raised its price target from 20 to 22. Kezar Life Sciences Inc NASDAQ. Crude Oil Down 1.

Announced that the Compensation Committee of the companys Board of Directors granted two employees nonqualified stock options to purchase an aggregate of 29000 shares of its common stock with an exercise price of 1254 per share which is equal to the closing price of Kezars common stock on May 2 2022 the. SOUTH SAN FRANCISCO Calif--BUSINESS WIRE-- Kezar Life Sciences Inc Nasdaq. Mid-Day Market Update.

KZR stock quote history news and other vital information to help you with your stock trading and investing. NASDAQKZR - Get Rating - Investment analysts at Jefferies Financial Group lifted their Q2 2022 earnings per share EPS estimates for shares of Kezar Life Sciences in a report issued on Tuesday May 3rd. KZR Complete Kezar Life Sciences Inc.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Stock analysis for Kezar Life Sciences Inc KZRNASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. Kwhen Dec 28 2021.

Find the latest Kezar Life Sciences Inc. Kezar Life Sciences market cap is 7235 m. Apr 14 40216 PM GMT-4 USD NASDAQ Disclaimer.

A high-level overview of Kezar Life Sciences Inc. In terms of relative price strength the Kezar Life Sciences share price has outperformed the SP500 Index by 14352 over the past year. View the latest Kezar Life Sciences Inc.

Shares in Kezar Life Sciences last closed at 1636 and the price had moved by 16472 over the past 365 days. Kezar Life Sciences Shares Surge Midway through trading Tuesday the Dow traded up 025 to 3617674 while the NASDAQ rose 019 to 1588375. Your current 100 investment may be up to 18238 in 2026.

HC Wainwright boosted their price objective on Kezar Life Sciences from 2000 to 2200 and gave the company a buy rating in a research note on Friday March 18th. Kezar Life Sciences KZR stock price revenue and financials. This suggests a possible upside of 1641 from the stocks current price.

On average they expect Kezar Life Sciences stock price to reach 1667 in the next year. KZR shares are trading higher by 50 at 1608 after HC Wainwright Co. Kezar Life Sciences Inc quote is equal to 4360 EUR at 2021-07-20.

View daily weekly or monthly format back to when Kezar Life Sciences Inc. 3 equities research analysts have issued twelve-month price objectives for Kezar Life Sciences shares. Finally HC Wainwright upped their price target on Kezar Life Sciences from 2000 to 2200 and gave the stock a buy rating in a report on Friday March 18th.

Kzr Institutional Ownership Kezar Life Sciences Inc Nasdaq Stock